Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

Nat Commun. 2022 Jan 26;13(1):521. doi: 10.1038/s41467-022-28130-0.

Abstract

HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-specific CD4 + T cells reveals an advanced Th1 differentiation pattern in controllers, except for the CCR5 marker, which is downregulated compared to specific cells of treated patients. Accordingly, controller specific CD4 + T cells show decreased susceptibility to CCR5-dependent HIV entry. Two controllers carried biallelic mutations impairing CCR5 surface expression, indicating that in rare cases CCR5 downregulation can have a direct genetic cause. Increased expression of β-chemokine ligands upon high-avidity antigen/TCR interactions contributes to autocrine CCR5 downregulation in controllers without CCR5 mutations. These findings suggest that genetic and functional regulation of the primary HIV coreceptor CCR5 play a key role in promoting natural HIV control.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology*
  • Chemokines
  • Down-Regulation
  • Elite Controllers*
  • Gene Expression Regulation
  • Gene Products, gag / metabolism
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV-1 / immunology*
  • Histocompatibility Antigens Class II
  • Humans
  • Mutation
  • Receptors, CCR5 / genetics
  • Receptors, CCR5 / metabolism*
  • Receptors, CXCR3
  • Virus Internalization*

Substances

  • CCR5 protein, human
  • CXCR3 protein, human
  • Chemokines
  • Gene Products, gag
  • Histocompatibility Antigens Class II
  • Receptors, CCR5
  • Receptors, CXCR3